Alpha 2.0
Login Register
» Articles » PMID: 7513336

Withdrawal Symptoms During Therapy with Transdermal Fentanyl (fentanyl TTS)?

Overview
Journal J Pain Symptom Manage
Publisher Elsevier
Specialties Critical Care
Pharmacology
Psychiatry
Date 1994 Jan 1
PMID 7513336
Citations 8
Authors
M Zenz
B Donner
M Strumpf
Affiliations
Soon will be listed here.
Citing Articles

Experience with transdermal fentanyl in a hospice setting.

Kelly P Clin Drug Investig. 2008; 16(1):84-7.

PMID: 18370524 DOI: 10.2165/00044011-199816010-00013.

Transdermal opioids for cancer pain.

Skaer T Health Qual Life Outcomes. 2006; 4:24.

PMID: 16573839 PMC: 1526423. DOI: 10.1186/1477-7525-4-24.

Practice guidelines for transdermal opioids in malignant pain.

Skaer T Drugs. 2004; 64(23):2629-38.

PMID: 15537367 DOI: 10.2165/00003495-200464230-00002.

Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.

Kornick C, Santiago-Palma J, Moryl N, Payne R, Obbens E Drug Saf. 2003; 26(13):951-73.

PMID: 14583070 DOI: 10.2165/00002018-200326130-00004.

Strategies for the treatment of cancer pain in the new millennium.

Ripamonti C, Dickerson E Drugs. 2001; 61(7):955-77.

PMID: 11434451 DOI: 10.2165/00003495-200161070-00005.